Clinical Trial Update: Myocardial Infarction Size Reduction With Atorvastatin [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating whether atorvastatin reduces myocardial infarct size and reperfusion injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Reperfusion Injury

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: R&D Cardiologie | Conditions: Myocardial Infarction, Reperfusion Injury | Phase 4 | Status: COMPLETED